Jennifer Champoux Insider Trades & Stock Holdings

Chief Operating Officer · Monte Rosa Therapeutics, Inc. · Latest filing Jun 23, 2026

Jennifer Champoux, Chief Operating Officer at Monte Rosa Therapeutics, Inc. has 4 Form 4 trades on file since Jun 17, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($41.34K), net -$41.34K. Latest filing: disposed of 2.17K shares of $GLUE on Jun 23, 2026.

Trades on file

4

Open-market bought

$0

Open-market sold

$41.34K

Net open-market

-$41.34K

Latest filing

Jun 23, 2026

All insider trades by Jennifer Champoux

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 23, 2026	$GLUE	Sell (Option exercise)	2.17K	$0	—			+16.9%	+11.2%		Chief Operating Officer		—
Jun 23, 2026	$GLUE	Buy (Option exercise)	2.17K	$3.98	$8.66K			+16.9%	+11.2%		Chief Operating Officer		—
Jun 17, 2026	$GLUE	Sell (Open-market sale) 10b5-1	2.18K	$19	$41.34K			+13.3%	+33.4%		Chief Operating Officer		—
Jun 17, 2026	$GLUE	Buy (Option exercise)	2.18K	$3.98	$8.66K			+13.3%	+33.4%		Chief Operating Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Jennifer Champoux traded

• $GLUE

Frequently asked questions

Has Jennifer Champoux been buying or selling stock?

Jennifer Champoux has 0 open-market purchases and 1 open-market sale on file, net -$41.34K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Jennifer Champoux's latest insider trade?

disposed of 2.17K shares of $GLUE on Jun 23, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.